Rachelle Suzanne Jacques - 26 Apr 2024 Form 4 Insider Report for Akari Therapeutics Plc (AKTX)

Role
Chief Executive Officer, Director
Signature
/s/ Rachelle Jacques
Issuer symbol
AKTX
Transactions as of
26 Apr 2024
Net transactions value
$0
Form type
4
Filing time
30 Apr 2024, 21:45:06 UTC
Previous filing
02 Jan 2024
Next filing
20 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKTX Ordinary Shares, par value $0.0001 per share Award $0 +479,569,892 +89% $0.000000 1,018,027,792 26 Apr 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs"), with each such RSU representing the right to receive one ordinary share, par value $0.0001. 50% of the RSUs shall vest on March 28, 2025, with the remainder vesting in 12 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.